Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 9,913,000 | 10,735,000 | 9,823,000 | 9,048,000 | 8,386,000 |
| Cost of Goods | 3,465,000 | 3,116,000 | 2,813,000 | 2,593,000 | 2,424,000 |
| Gross Profit | 6,448,000 | 7,620,000 | 7,011,000 | 6,455,000 | 5,962,000 |
| Operating Expenses | 6,527,000 | 6,102,000 | 5,504,000 | 5,170,000 | 5,515,000 |
| Operating Income | -80,000 | 1,518,000 | 1,506,000 | 1,285,000 | 447,000 |
| Interest Expense | 361,000 | 473,000 | 241,000 | 229,000 | 233,000 |
| Other Income | 362,000 | -358,000 | 157,000 | -123,000 | -37,000 |
| Pre-tax Income | -79,000 | 687,000 | 1,422,000 | 933,000 | 177,000 |
| Income Tax | 2,000 | -4,013,000 | -249,000 | 828,000 | -170,000 |
| Net Income Continuous | -81,000 | 4,700,000 | 1,671,000 | 105,000 | 347,000 |
| Net Income | $-82,000 | $4,700,000 | $1,671,000 | $105,000 | $347,000 |
| EPS Basic Total Ops | -0.08 | 3.38 | 1.21 | 0.08 | 0.26 |
| EPS Basic Continuous Ops | -0.06 | 3.38 | 1.21 | 0.08 | 0.26 |
| EPS Diluted Total Ops | -0.08 | 3.33 | 1.19 | 0.08 | 0.25 |
| EPS Diluted Continuous Ops | -0.06 | 3.33 | 1.19 | 0.08 | 0.25 |
| EPS Diluted Before Non-Recurring Items | 0.96 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,577,000 | $2,633,000 | $2,435,000 | $2,133,000 | $1,273,000 |